T. Nishiwaki
Papers
2
Total Citations
2
H-Index
1
About
T. Nishiwaki is a leading urologic surgeon and researcher whose work focuses on advancing the surgical management of bladder cancer, particularly through robotic-assisted techniques. Their major contributions center on optimizing outcomes for patients undergoing robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion, a technically demanding procedure that offers significant minimally invasive benefits. In a 2024 narrative review, Nishiwaki comprehensively analyzed surgical outcomes and perioperative complications of intracorporeal ileal neobladder reconstruction, providing critical insights for surgeons navigating this complex approach. Building on this foundation, their 2025 study investigated the significance of split-dose cisplatin-based neoadjuvant chemotherapy prior to RARC for muscle-invasive bladder cancer—a strategy designed to mitigate nephrotoxicity while preserving oncologic efficacy. This work addresses a pressing clinical challenge, as cisplatin remains essential yet renally toxic. Though early in their citation trajectory, Nishiwaki’s research is already shaping best practices in robotic urologic oncology, bridging the gap between aggressive chemotherapy regimens and advanced surgical innovation. Their contributions promise to improve both safety and outcomes for patients facing this devastating disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2